Teriflunomide Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Tablets, Powder); Application (Immunosuppression, Cancer Treatment, Multiple sclerosis, Others) and Geography
Report Code: TIPRE00018996 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Teriflunomide is an immunomodulatory agent and is an active metabolite of leflunomide. Teriflunomide is sold under prescription category medication for the treatment of relapsing forms of multiple sclerosis in adults and have not significant therapeutic effects in children. Teriflunomide acts by inhibiting pyrimidine de novo synthesis by blocking enzyme dihydroorotate dehydrogenase. The side effects of teriflunomide include, body aches, fever, tiredness, vomiting.
MARKET DYNAMICS
The key market drivers for Teriflunomide Market Includes, rising incidences of chronic disorders along with high prevalence of multiple sclerosis. Moreover, rising R&D investment by pharmaceutical companies to fill ANDA applications for developing novel therapies is also expected to fuel market growth. Additionally growing demand for immunomodulatory agents is also expected to boost market growth. However, stringent regulations by drug regulating bodies and potential side effects from treatment is expected to restrain market growth during forecast period.
MARKET SCOPE
The "Teriflunomide Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Teriflunomide market with detailed market segmentation by type and application. The Teriflunomide Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Teriflunomide Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Teriflunomide Market is segmented on the basis of type and application. On the basis of type the market is segmented as, tablets and powder. And on the basis of application the market is segmented as, immunosuppression, cancer treatment, multiple sclerosis, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Teriflunomide Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Teriflunomide Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Teriflunomide Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Teriflunomide Market in these regions.
The report covers key developments in the Teriflunomide Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Teriflunomide Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Teriflunomide market in the global market. Below mentioned is the list of few companies engaged in the Teriflunomide Market.
The report also includes the profiles of key players in Teriflunomide Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Teriflunomide is an immunomodulatory agent and is an active metabolite of leflunomide. Teriflunomide is sold under prescription category medication for the treatment of relapsing forms of multiple sclerosis in adults and have not significant therapeutic effects in children. Teriflunomide acts by inhibiting pyrimidine de novo synthesis by blocking enzyme dihydroorotate dehydrogenase. The side effects of teriflunomide include, body aches, fever, tiredness, vomiting.
MARKET DYNAMICS
The key market drivers for Teriflunomide Market Includes, rising incidences of chronic disorders along with high prevalence of multiple sclerosis. Moreover, rising R&D investment by pharmaceutical companies to fill ANDA applications for developing novel therapies is also expected to fuel market growth. Additionally growing demand for immunomodulatory agents is also expected to boost market growth. However, stringent regulations by drug regulating bodies and potential side effects from treatment is expected to restrain market growth during forecast period.
MARKET SCOPE
The "Teriflunomide Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Teriflunomide market with detailed market segmentation by type and application. The Teriflunomide Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Teriflunomide Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Teriflunomide Market is segmented on the basis of type and application. On the basis of type the market is segmented as, tablets and powder. And on the basis of application the market is segmented as, immunosuppression, cancer treatment, multiple sclerosis, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Teriflunomide Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Teriflunomide Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Teriflunomide Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Teriflunomide Market in these regions.
The report covers key developments in the Teriflunomide Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Teriflunomide Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Teriflunomide market in the global market. Below mentioned is the list of few companies engaged in the Teriflunomide Market.
The report also includes the profiles of key players in Teriflunomide Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Sanofi Aventis
- Genzyme Corporation
- Amneal Pharmaceuticals NY LC
- Sigma- Aldrich
- Glenmark Pharmaceuticals
- MSN Laboratories Private Limited
- Alembic pharmaceuticals
- Natco
- Midas Pharma GmbH
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Teriflunomide Market - By Type
1.3.2 Teriflunomide Market - By Application
1.3.3 Teriflunomide Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TERIFLUNOMIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TERIFLUNOMIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TERIFLUNOMIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. TERIFLUNOMIDE - GLOBAL MARKET OVERVIEW
6.2. TERIFLUNOMIDE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. TERIFLUNOMIDE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TABLETS
7.3.1. Overview
7.3.2. Tablets Market Forecast and Analysis
7.4. POWDER
7.4.1. Overview
7.4.2. Powder Market Forecast and Analysis
8. TERIFLUNOMIDE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOSUPPRESSION
8.3.1. Overview
8.3.2. Immunosuppression Market Forecast and Analysis
8.4. CANCER TREATMENT
8.4.1. Overview
8.4.2. Cancer Treatment Market Forecast and Analysis
8.5. MULTIPLE SCLEROSIS
8.5.1. Overview
8.5.2. Multiple sclerosis Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. TERIFLUNOMIDE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Teriflunomide Market Overview
9.1.2 North America Teriflunomide Market Forecasts and Analysis
9.1.3 North America Teriflunomide Market Forecasts and Analysis - By Type
9.1.4 North America Teriflunomide Market Forecasts and Analysis - By Application
9.1.5 North America Teriflunomide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Teriflunomide Market
9.1.5.1.1 United States Teriflunomide Market by Type
9.1.5.1.2 United States Teriflunomide Market by Application
9.1.5.2 Canada Teriflunomide Market
9.1.5.2.1 Canada Teriflunomide Market by Type
9.1.5.2.2 Canada Teriflunomide Market by Application
9.1.5.3 Mexico Teriflunomide Market
9.1.5.3.1 Mexico Teriflunomide Market by Type
9.1.5.3.2 Mexico Teriflunomide Market by Application
9.2. EUROPE
9.2.1 Europe Teriflunomide Market Overview
9.2.2 Europe Teriflunomide Market Forecasts and Analysis
9.2.3 Europe Teriflunomide Market Forecasts and Analysis - By Type
9.2.4 Europe Teriflunomide Market Forecasts and Analysis - By Application
9.2.5 Europe Teriflunomide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Teriflunomide Market
9.2.5.1.1 Germany Teriflunomide Market by Type
9.2.5.1.2 Germany Teriflunomide Market by Application
9.2.5.2 France Teriflunomide Market
9.2.5.2.1 France Teriflunomide Market by Type
9.2.5.2.2 France Teriflunomide Market by Application
9.2.5.3 Italy Teriflunomide Market
9.2.5.3.1 Italy Teriflunomide Market by Type
9.2.5.3.2 Italy Teriflunomide Market by Application
9.2.5.4 Spain Teriflunomide Market
9.2.5.4.1 Spain Teriflunomide Market by Type
9.2.5.4.2 Spain Teriflunomide Market by Application
9.2.5.5 United Kingdom Teriflunomide Market
9.2.5.5.1 United Kingdom Teriflunomide Market by Type
9.2.5.5.2 United Kingdom Teriflunomide Market by Application
9.2.5.6 Rest of Europe Teriflunomide Market
9.2.5.6.1 Rest of Europe Teriflunomide Market by Type
9.2.5.6.2 Rest of Europe Teriflunomide Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Teriflunomide Market Overview
9.3.2 Asia-Pacific Teriflunomide Market Forecasts and Analysis
9.3.3 Asia-Pacific Teriflunomide Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Teriflunomide Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Teriflunomide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Teriflunomide Market
9.3.5.1.1 Australia Teriflunomide Market by Type
9.3.5.1.2 Australia Teriflunomide Market by Application
9.3.5.2 China Teriflunomide Market
9.3.5.2.1 China Teriflunomide Market by Type
9.3.5.2.2 China Teriflunomide Market by Application
9.3.5.3 India Teriflunomide Market
9.3.5.3.1 India Teriflunomide Market by Type
9.3.5.3.2 India Teriflunomide Market by Application
9.3.5.4 Japan Teriflunomide Market
9.3.5.4.1 Japan Teriflunomide Market by Type
9.3.5.4.2 Japan Teriflunomide Market by Application
9.3.5.5 South Korea Teriflunomide Market
9.3.5.5.1 South Korea Teriflunomide Market by Type
9.3.5.5.2 South Korea Teriflunomide Market by Application
9.3.5.6 Rest of Asia-Pacific Teriflunomide Market
9.3.5.6.1 Rest of Asia-Pacific Teriflunomide Market by Type
9.3.5.6.2 Rest of Asia-Pacific Teriflunomide Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Teriflunomide Market Overview
9.4.2 Middle East and Africa Teriflunomide Market Forecasts and Analysis
9.4.3 Middle East and Africa Teriflunomide Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Teriflunomide Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Teriflunomide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Teriflunomide Market
9.4.5.1.1 South Africa Teriflunomide Market by Type
9.4.5.1.2 South Africa Teriflunomide Market by Application
9.4.5.2 Saudi Arabia Teriflunomide Market
9.4.5.2.1 Saudi Arabia Teriflunomide Market by Type
9.4.5.2.2 Saudi Arabia Teriflunomide Market by Application
9.4.5.3 U.A.E Teriflunomide Market
9.4.5.3.1 U.A.E Teriflunomide Market by Type
9.4.5.3.2 U.A.E Teriflunomide Market by Application
9.4.5.4 Rest of Middle East and Africa Teriflunomide Market
9.4.5.4.1 Rest of Middle East and Africa Teriflunomide Market by Type
9.4.5.4.2 Rest of Middle East and Africa Teriflunomide Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Teriflunomide Market Overview
9.5.2 South and Central America Teriflunomide Market Forecasts and Analysis
9.5.3 South and Central America Teriflunomide Market Forecasts and Analysis - By Type
9.5.4 South and Central America Teriflunomide Market Forecasts and Analysis - By Application
9.5.5 South and Central America Teriflunomide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Teriflunomide Market
9.5.5.1.1 Brazil Teriflunomide Market by Type
9.5.5.1.2 Brazil Teriflunomide Market by Application
9.5.5.2 Argentina Teriflunomide Market
9.5.5.2.1 Argentina Teriflunomide Market by Type
9.5.5.2.2 Argentina Teriflunomide Market by Application
9.5.5.3 Rest of South and Central America Teriflunomide Market
9.5.5.3.1 Rest of South and Central America Teriflunomide Market by Type
9.5.5.3.2 Rest of South and Central America Teriflunomide Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. TERIFLUNOMIDE MARKET, KEY COMPANY PROFILES
11.1. SANOFI AVENTIS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GENZYME CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. AMNEAL PHARMACEUTICALS NY LC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLENMARK PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MSN LABORATORIES PRIVATE LIMITED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ALEMBIC PHARMACEUTICALS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NATCO
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SIGMA- ALDRICH
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MIDAS PHARMA GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Teriflunomide Market - By Type
1.3.2 Teriflunomide Market - By Application
1.3.3 Teriflunomide Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TERIFLUNOMIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TERIFLUNOMIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TERIFLUNOMIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. TERIFLUNOMIDE - GLOBAL MARKET OVERVIEW
6.2. TERIFLUNOMIDE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. TERIFLUNOMIDE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TABLETS
7.3.1. Overview
7.3.2. Tablets Market Forecast and Analysis
7.4. POWDER
7.4.1. Overview
7.4.2. Powder Market Forecast and Analysis
8. TERIFLUNOMIDE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOSUPPRESSION
8.3.1. Overview
8.3.2. Immunosuppression Market Forecast and Analysis
8.4. CANCER TREATMENT
8.4.1. Overview
8.4.2. Cancer Treatment Market Forecast and Analysis
8.5. MULTIPLE SCLEROSIS
8.5.1. Overview
8.5.2. Multiple sclerosis Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. TERIFLUNOMIDE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Teriflunomide Market Overview
9.1.2 North America Teriflunomide Market Forecasts and Analysis
9.1.3 North America Teriflunomide Market Forecasts and Analysis - By Type
9.1.4 North America Teriflunomide Market Forecasts and Analysis - By Application
9.1.5 North America Teriflunomide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Teriflunomide Market
9.1.5.1.1 United States Teriflunomide Market by Type
9.1.5.1.2 United States Teriflunomide Market by Application
9.1.5.2 Canada Teriflunomide Market
9.1.5.2.1 Canada Teriflunomide Market by Type
9.1.5.2.2 Canada Teriflunomide Market by Application
9.1.5.3 Mexico Teriflunomide Market
9.1.5.3.1 Mexico Teriflunomide Market by Type
9.1.5.3.2 Mexico Teriflunomide Market by Application
9.2. EUROPE
9.2.1 Europe Teriflunomide Market Overview
9.2.2 Europe Teriflunomide Market Forecasts and Analysis
9.2.3 Europe Teriflunomide Market Forecasts and Analysis - By Type
9.2.4 Europe Teriflunomide Market Forecasts and Analysis - By Application
9.2.5 Europe Teriflunomide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Teriflunomide Market
9.2.5.1.1 Germany Teriflunomide Market by Type
9.2.5.1.2 Germany Teriflunomide Market by Application
9.2.5.2 France Teriflunomide Market
9.2.5.2.1 France Teriflunomide Market by Type
9.2.5.2.2 France Teriflunomide Market by Application
9.2.5.3 Italy Teriflunomide Market
9.2.5.3.1 Italy Teriflunomide Market by Type
9.2.5.3.2 Italy Teriflunomide Market by Application
9.2.5.4 Spain Teriflunomide Market
9.2.5.4.1 Spain Teriflunomide Market by Type
9.2.5.4.2 Spain Teriflunomide Market by Application
9.2.5.5 United Kingdom Teriflunomide Market
9.2.5.5.1 United Kingdom Teriflunomide Market by Type
9.2.5.5.2 United Kingdom Teriflunomide Market by Application
9.2.5.6 Rest of Europe Teriflunomide Market
9.2.5.6.1 Rest of Europe Teriflunomide Market by Type
9.2.5.6.2 Rest of Europe Teriflunomide Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Teriflunomide Market Overview
9.3.2 Asia-Pacific Teriflunomide Market Forecasts and Analysis
9.3.3 Asia-Pacific Teriflunomide Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Teriflunomide Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Teriflunomide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Teriflunomide Market
9.3.5.1.1 Australia Teriflunomide Market by Type
9.3.5.1.2 Australia Teriflunomide Market by Application
9.3.5.2 China Teriflunomide Market
9.3.5.2.1 China Teriflunomide Market by Type
9.3.5.2.2 China Teriflunomide Market by Application
9.3.5.3 India Teriflunomide Market
9.3.5.3.1 India Teriflunomide Market by Type
9.3.5.3.2 India Teriflunomide Market by Application
9.3.5.4 Japan Teriflunomide Market
9.3.5.4.1 Japan Teriflunomide Market by Type
9.3.5.4.2 Japan Teriflunomide Market by Application
9.3.5.5 South Korea Teriflunomide Market
9.3.5.5.1 South Korea Teriflunomide Market by Type
9.3.5.5.2 South Korea Teriflunomide Market by Application
9.3.5.6 Rest of Asia-Pacific Teriflunomide Market
9.3.5.6.1 Rest of Asia-Pacific Teriflunomide Market by Type
9.3.5.6.2 Rest of Asia-Pacific Teriflunomide Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Teriflunomide Market Overview
9.4.2 Middle East and Africa Teriflunomide Market Forecasts and Analysis
9.4.3 Middle East and Africa Teriflunomide Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Teriflunomide Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Teriflunomide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Teriflunomide Market
9.4.5.1.1 South Africa Teriflunomide Market by Type
9.4.5.1.2 South Africa Teriflunomide Market by Application
9.4.5.2 Saudi Arabia Teriflunomide Market
9.4.5.2.1 Saudi Arabia Teriflunomide Market by Type
9.4.5.2.2 Saudi Arabia Teriflunomide Market by Application
9.4.5.3 U.A.E Teriflunomide Market
9.4.5.3.1 U.A.E Teriflunomide Market by Type
9.4.5.3.2 U.A.E Teriflunomide Market by Application
9.4.5.4 Rest of Middle East and Africa Teriflunomide Market
9.4.5.4.1 Rest of Middle East and Africa Teriflunomide Market by Type
9.4.5.4.2 Rest of Middle East and Africa Teriflunomide Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Teriflunomide Market Overview
9.5.2 South and Central America Teriflunomide Market Forecasts and Analysis
9.5.3 South and Central America Teriflunomide Market Forecasts and Analysis - By Type
9.5.4 South and Central America Teriflunomide Market Forecasts and Analysis - By Application
9.5.5 South and Central America Teriflunomide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Teriflunomide Market
9.5.5.1.1 Brazil Teriflunomide Market by Type
9.5.5.1.2 Brazil Teriflunomide Market by Application
9.5.5.2 Argentina Teriflunomide Market
9.5.5.2.1 Argentina Teriflunomide Market by Type
9.5.5.2.2 Argentina Teriflunomide Market by Application
9.5.5.3 Rest of South and Central America Teriflunomide Market
9.5.5.3.1 Rest of South and Central America Teriflunomide Market by Type
9.5.5.3.2 Rest of South and Central America Teriflunomide Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. TERIFLUNOMIDE MARKET, KEY COMPANY PROFILES
11.1. SANOFI AVENTIS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GENZYME CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. AMNEAL PHARMACEUTICALS NY LC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLENMARK PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MSN LABORATORIES PRIVATE LIMITED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ALEMBIC PHARMACEUTICALS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NATCO
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SIGMA- ALDRICH
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MIDAS PHARMA GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Sanofi Aventis
2. Genzyme Corporation
3. Amneal Pharmaceuticals NY LC
4. Glenmark Pharmaceuticals
5. Msn Laboratories Private Limited
6. Alembic Pharmaceuticals
7. Natco
8. Sigma- Aldrich
9. Midas Pharma GmbH
1. Sanofi Aventis
2. Genzyme Corporation
3. Amneal Pharmaceuticals NY LC
4. Glenmark Pharmaceuticals
5. Msn Laboratories Private Limited
6. Alembic Pharmaceuticals
7. Natco
8. Sigma- Aldrich
9. Midas Pharma GmbH